UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008720
Receipt number R000010230
Scientific Title Reserch for clinical indicatior of pathophisiology of classic asthma and cough variant asthma -remission after inhaled corticosteroid treatment in cough variant asthma-
Date of disclosure of the study information 2012/08/24
Last modified on 2018/08/24 10:16:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reserch for clinical indicatior of pathophisiology of classic asthma and cough variant asthma -remission after inhaled corticosteroid treatment in cough variant asthma-

Acronym

remission of cough variant asthma

Scientific Title

Reserch for clinical indicatior of pathophisiology of classic asthma and cough variant asthma -remission after inhaled corticosteroid treatment in cough variant asthma-

Scientific Title:Acronym

remission of cough variant asthma

Region

Japan


Condition

Condition

cough variant asthma

Classification by specialty

Pneumology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to clarify the proportion of remission in cough variant asthma

Basic objectives2

Others

Basic objectives -Others

pathophysiology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the proportion of remission and recurrence in cough variant asthma

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

cough variant asthma

Key exclusion criteria

chronic obstructive pulmonary desease,interstitial pneumonia,lung cancer,pulmonary tuberculosis,
bacterial pneumonia

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisako Matsumoto

Organization

Graduate School of Medicine, Kyoto University

Division name

Respiratory Medicine

Zip code


Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan

TEL

075-751-3830

Email

hmatsumo@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tadao Nagasaki

Organization

Graduate School of Medicine, Kyoto University

Division name

Respiratory Medicine

Zip code


Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan

TEL

075-751-3830

Homepage URL


Email

nagasaki@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

scholarship

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

E1225

Org. issuing International ID_1

Ethics Committee of Kyoto University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 08 Month 18 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

to investigate changes in hyperresponsiveness after inhaled corticosteroid cessation in cough variant asthma


Management information

Registered date

2012 Year 08 Month 18 Day

Last modified on

2018 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010230


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name